“⚕베스트토토검증【평생베스트.com】베스트토토놀이터⚕”的搜索结果，显示 101-110 项，共有 14655 项

1. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   ... best overall response rate (BORR) of combined ramucirumab (RAM) plus paclitaxel (+/- pembrolizumab) following induction pembrolizumab (PEM) in patients with ...

2. 外科 - 临床试验- 妙佑医疗国际

   This study is designed to: -analyze effects of surgical treatment -improve surgical care and quality of life of patients with hip problems/diseases

3. 肾病和高血压- 临床试验- 妙佑医疗国际

   Rochester, Minn. The purpose of this study is to determine if Obinutuzumab is effective and safe in treating patients with fibrillary glomerulonephritis. A ...

4. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   This phase I trial evaluates the safety, effectiveness, and best dose of onvansertib for the treatment of patients with chronic myelomonocytic leukemia that ...

5. 血液科- 临床试验- 妙佑医疗国际

   ... best ways to help patients adhere to oral chemotherapy regimens. Finally, this study will be the first to track the outcomes of subjects with disseminated B ...

6. 血液科- 临床试验- 妙佑医疗国际

   ... best ways to help patients adhere to oral chemotherapy regimens. Finally, this study will be the first to track the outcomes of subjects with disseminated B ...

7. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   This phase Ib trial studies the side effects and best dose of a vaccine called H2NVAC before surgery in treating patients with HER2 expressing ductal carcinoma ...

8. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   This phase I trial studies the best dose and side effects of recombinant vesicular stomatitis virus carrying the human NIS and IFN beta genes (VSV-hIFNbeta- ...

9. 放射科- 临床试验- 妙佑医疗国际

   Accurate, MR based kidney volume measurements are the best parameter for following the progression of ADPKD, and are suggested be acquired to measure ...

10. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

    ... best overall response rate (BORR) of combined ramucirumab (RAM) plus paclitaxel (+/- pembrolizumab) following induction pembrolizumab (PEM) in patients with ...